Ibhande kanye Nomgwaqo: Ukubambisana, Ukuvumelana kanye Win-Win
imikhiqizo

Imikhiqizo

I-Doxazosin Mesylate CAS:77883-43-3 Umhlinzeki Womkhiqizi

I-Doxazosin mesylate iyinhlanganisela ye-quinazoline eyi-inhibitor ekhethiwe ye-alpha1 subtype ye-alpha adrenergic receptors.I-Doxazosin mesylate isizukulwane esisha se-quinazolone α1 receptor blocker eyakhiwe yinkampani ye-Pfizer (United States), Inesigamu sempilo ende, yenza imiphumela yayo yokunweba imithambo yegazi, inciphise ukumelana nemithambo kanye nokwehlisa umfutho wegazi ngokuvimbela imithambo yegazi. i-receptor engu-1.Kuye kwatuswa emazweni angaphandle njengemithi yomtholampilo yokuqala ye-anti-hypertension kanye nokwelashwa kwesifo se-prostate.


Imininingwane Yomkhiqizo

Omaka bomkhiqizo

Isicelo kanye Nomphumela

I-Doxazosin mesylate iyi-blocker entsha ekhethwa kakhulu ye-α1, enomthelela omkhulu wokubangela ukwehla komfutho wegazi kuyilapho inomthelela omuhle wokunciphisa i-lipid metabolism.Kunganciphisa kakhulu i-serum triglycerides kanye ne-cholesterol ephelele;ingase futhi ivimbele ngokukhetha i-a1 adrenergic receptor ye-prostate smooth muscle matrix, i-capsule nentamo yesinye, inciphise izimpawu ze-benign prostatic hyperplasia iziguli, inciphise kakhulu umphumela we-benign prostatic hyperplasia, ikakhulukazi ibe nomthelela omuhle ekwelapheni i-dysuria ebangelwa. nge-prostatic hyperplasia elula.Inokuphila kwesigamu eside.Kungase kube nesiyezi, umlomo owomile, ikhanda elibuhlungu, ukushaya kwenhliziyo, ukukhathala, izimpawu zithambile, ziyabekezeleleka, zinyamalale phakathi nesonto elingu-1, ngaphandle kokwelashwa okukhethekile.Akukho hypotension ye-postural eyenzeka.

Isampula Lomkhiqizo

图片79(1)(1)
图片80(3)

Ukupakishwa komkhiqizo:

图片81(1)

Ulwazi Olwengeziwe:

Ukwakheka I-C24H29N5O8S
Isivivinyo 99%
Ukubukeka Impushana emhlophe
Inombolo ye-CAS. 77883-43-3
Ukupakisha 25KG
I-Shelf Life iminyaka engu-2
Isitoreji Gcina endaweni epholile neyomile
Isitifiketi ISO.

  • Okwedlule:
  • Olandelayo:

  • Bhala umyalezo wakho lapha futhi usithumelele wona